MedTrace Logo

Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients

NCT01865045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-09-10

No results posted yet for this study

Summary

This is a multicenter retrospective analysis .The aim of the present study is to investigate the molecular predictors of vinorelbine response in tumor samples of a series of MPM patients and evaluate the possible impact on clinical outcome.

Sample size: around 150 patients based on the availability of tumor size

Conditions

  • Malignant Pleural Mesothelioma

Sponsors & Collaborators

  • Armando Santoro, MD

    lead OTHER

Principal Investigators

  • armando santoro, MD · Istituto Clinico Humanitas

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01865045 on ClinicalTrials.gov